Emerging opportunities in diagnostics include rapid and point-of-care testing, consumer markets, and biomarker development. Immunoassays are expanding due to genetic advances, with multiplex becoming ...

Organic field-effect transistors (OFETs) have established themselves as versatile platforms for sensing and optoelectronic detection, benefiting from ...

The rise of OTC and DTC diagnostics, driven by advancements in rapid and multiplex testing for home use, presents significant market opportunities. The shift towards consumer-accessible infectious ...

Dexcom, Inc. , the global leader in glucose biosensing, announced it will roll out an advanced AI-enabled enhancement to Stelo that will transform how users understand their glucose health and take ...

GÖTEBORG, SE / ACCESS Newswire / February 4, 2026 / Smart Eye Aktiebolag (publ) ("Smart Eye") (STO:SEYE)(FRA:SE9) has entered into an agreement to acquire all shares in the Swedish AI-based software ...